AzTrials
AzTrials

FallGAPcareIINCT04304495

The Geriatric Acute & Post-acute Care Coordination Program for Fall Prevention in the Emergency Department II

A study testing Fall Prevention in people with Fall, run by University of Colorado, Denver at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In brief, this K76 study consists of a small open trial to refine the study protocol and train study personnel on study procedures (Aim 1.b.). In Aim 2, we will recruit older adults into a multidisciplinary fall prevention pilot study. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Fall
What is being tested?
Fall Prevention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
197 participants
Where
3 sitesUnited States
Study dates
6 Jan 2021to 2 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Community-dwelling adult (non-institutionalized) 65 years-old or older presenting to ED after a fall
  • Fall not due to syncope or external force (i.e., struck by car or assault)
  • Fall not due to serious illness (i.e., stroke, acute myocardial infarction)
  • Will be discharged to home/assisted living/rehabilitation at completion of ED visit (i.e., not admitted)
  • Legally authorized representative able to give informed consent if patient has cognitive impairment on Six Item Screener (score of less than four) either over the phone with witness present or in person
  • Must screen or test negative for COVID-19

Who cannot join

  • Unable to give informed consent due to intoxication or altered mental status
  • Presence of injuries that prevent mobilization (i.e., pelvic or lower extremity fractures)
  • Allergies to any wearable device component
  • Unable or unwilling to wear Apple Watch at home (only for periodic study visits)
  • Patient has advanced cancer and/or is on hospice care
  • Pts coming from SNF or nursing home
  • Previously enrolled in GAPcare II Aim1.b

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • University of Colorado Hospital

    Aurora, Colorado, 80045

  • Rhode Island Hospital

    Providence, Rhode Island, 02903

  • The Miriam Hospital

    Providence, Rhode Island, 02906

Other trials in United States

About this study

Official title: GAPcare II: The Geriatric Acute & Post-acute Care Coordination Program for Fall Prevention in the Emergency Department

In brief, this K76 study consists of a small open trial to refine the study protocol and train study personnel on study procedures (Aim 1.b.). In Aim 2, we will recruit older adults into a multidisciplinary fall prevention pilot study. Participants will be randomly assigned to usual care with a traditional fall evaluation by an ED clinician (i.e., ED medical staff member) or an intervention. In the intervention, participants will receive an in-ED consultation by a physical therapist and pharmacist to determine reasons for the fall and offer additional education and training. Participants will be provided an Apple Watch to record measures of fitness and falls, if possible, in the following 12 months. Recurrent falls will be measured in twelve-month follow-up.

Read the detailed description

In order to determine whether a multifactorial fall prevention intervention is feasible, acceptable and may reduce recurrent falls in older adults presenting to the ED after a fall, we will randomize patients to usual care with a traditional fall evaluation by an ED clinician or an intervention. Patients in the intervention arm receive a fall risk assessment and recommendations by a physical therapist. They are also evaluated by a pharmacist and participate in a medication therapy management session with the aim to reduce fall risk increasing medication.

Conditions
Fall
Being tested
Fall Prevention
Keywords
prevention, emergency department, digital health, Apple Watch, physical therapy, pharmacy, GAPcare, Geriatric
Medical subject headings
Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fall PreventionOther

    The intervention arm participants will receive a physical therapy and pharmacy consults as well as Apple Watch training and an Apple Watch device to test memory and mobility during the ED visit and during our home visits.

Study groups in NCT04304495
Study groupRoleWhat they receive
InterventionExperimentalIn addition to the usual care arm, the Intervention arm will receive a physical therapy and pharmacy consultation in the ED. PTs will perform a fall risk assessment and provide recommendations on the safety of discharge. Pharmacists will perform medication review, recommend cessation or tapering of medication that increase fall risk using motivational interviewing (MTM) techniques. The participants will also receive Apple Watch training and an Apple Watch to perform tasks that test their memory and mobility during their ED visit and during our home visits at 1,3, 6, and 12 month after enrollment.
Receives: Other: Fall Prevention
Usual care armNo interventionThe ED clinician will perform a standard medical evaluation, including a focused history and exam to identify injuries, laboratory tests and radiologic imaging. If necessary, the patient will receive consultation with specialty services (e.g., orthopedics). The participants will also receive Apple Watch training and an Apple Watch to perform tasks that test their memory and mobility during their ED visit and during our home visits at 1,3, 6, and 12 month after enrollment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of study activity completion

    Rate of participants who completed all study activities, including initial enrollment and multiple follow up visits over a 12 month period

    Measured: 12 months

Secondary outcomes (7)
  1. Change in gait speed

    Apple watch determined; average change in gait speed over 12-month follow-up

    Measured: 12 months

  2. Change in activity level

    Apple watch determined; average change in proportion of time spent active per day (e.g. walking, running, not driving or sedentary)

    Measured: 12 months

  3. Number of recurrent falls

    Number of falls in person months

    Measured: 12 months

  4. Number of ED re-visits

    Any visit to the ED in the 12-month follow-up

    Measured: 12 months

  5. Rate of hospitalization

    Any hospital admission in the 12-month follow-up

    Measured: 12 months

  6. Rate of permanent moves to nursing homes

    Any move to a nursing home for >30 days

    Measured: 12 months

  7. Mortality rate

    All cause patient mortality in follow-up

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Mar 2020
  2. Study start6 Jan 2021
  3. Primary completion2 Feb 2025
  4. Study completion2 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
197 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04304495
Sponsor's protocol ID
22-2089
Other IDs
K76AG059983
Acronym
GAPcareII
Status last verified
May 2025
First submitted
6 Dec 2019
Last updated
31 May 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Strauss DH, Davoodi NM, Healy M, Metts CL, Merchant RC, Banskota S, Goldberg EM. The Geriatric Acute and Post-Acute Fall Prevention Intervention (GAPcare) II to Assess the Use of the Apple Watch in Older Emergency Department Patients With Falls: Protocol for a Mixed Methods Study. JMIR Res Protoc. 2021 Apr 1;10(4):e24455. doi: 10.2196/24455.

    PubMed 33792553
  • Hartman CA, Leroux A, Merchant RC, Roberts S, Bettcher BM, Lum HD, Resnik L, Berry SD, Mealer M, Mor V, Goldberg E. Smartphone-Based Measurement of Cognition and Physical Function in Older Emergency Department Patients: A Feasibility Study. Acad Emerg Med. 2026 Sep;33(9):e70408. doi: 10.1111/acem.70408.

    PubMed 42775945

Questions about this trial

What is this clinical trial studying?

A study testing Fall Prevention in people with Fall, run by University of Colorado, Denver at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of study activity completion (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04304495, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 May 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
GAPcareII Clinical Trial NCT04304495 | AzTrials